Sep'05 | Sep'06 | Sep'07 | Sep'08 | Sep'09 | Sep'10 | Sep'11 | Sep'12 | Sep'13 | Sep'14 | Sep'15 | Sep'16 | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | $0.3 | $0.3 | $0.9 | ($1.6) | ($8.5) | ($0.2) | $0.6 | ($0.3) | ($4.4) | $0.1 | $0.5 | $1.2 | $2.7 | ($0.4) | ($0.2) | $4.2 | $7.3 | $5.2 | $1.9 | $3.4 |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Hologic, Inc.'s last 12-month EPS is $3.3, based on the financial report for Sep 28, 2024 (Q3 2024).
Over the last year, Hologic, Inc.'s EPS growth was 80.5%. The average annual EPS growth rates for Hologic, Inc. have been (23.2%) over the past three years, N/A over the past five years.
Over the last year, Hologic, Inc.'s EPS growth was 80.5%, which is higher than industry growth of 3.3%. It indicates that Hologic, Inc.'s EPS growth is Good.